Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $5.06 | $5.06 | $5.06 |
Q2 2024 | 6 | $4.93 | $4.93 | $4.93 |
Q3 2024 | 8 | $4.92 | $5.00 | $4.96 |
Q4 2024 | 14 | $5.95 | $6.54 | $6.14 |
Q1 2025 | 10 | $5.52 | $6.09 | $5.83 |
Q2 2025 | 9 | $6.11 | $6.36 | $6.23 |
Q3 2025 | 9 | $5.48 | $5.70 | $5.58 |
Q4 2025 | 9 | $6.82 | $7.10 | $6.95 |
Q1 2026 | 8 | $6.24 | $6.50 | $6.36 |
Q2 2026 | 8 | $6.58 | $6.85 | $6.70 |
Q3 2026 | 8 | $5.96 | $6.20 | $6.07 |
Q4 2026 | 8 | $7.40 | $7.70 | $7.54 |
HCA Healthcare, Inc. last posted its earnings results on Friday, October 25th, 2024. The company reported $5.03 earnings per share for the quarter, topping analysts' consensus estimates of $4.99 by $0.04. The company had revenue of 17.49 B for the quarter and had revenue of 64.97 B for the year. HCA Healthcare, Inc. has generated $19 earnings per share over the last year ($18.96 diluted earnings per share) and currently has a price-to-earnings ratio of 13.15. HCA Healthcare, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 28th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/31/2024 | Q3 2024 | $4.95 | $17.54 B | $17.49 B | ||
07/29/2024 | Q2 2024 | $5.55 | $17.05 B | $17.49 B | ||
05/02/2024 | Q1 2024 | $6.04 | $17.34 B | |||
02/16/2024 | Q4 2023 | $6.05 | $17.30 B | |||
10/26/2023 | Q3 2023 | $3.98 | $15.82 B | $16.21 B | ||
08/02/2023 | Q2 2023 | $4.35 | $15.63 B | $15.86 B | ||
04/27/2023 | Q1 2023 | $4.92 | $15.59 B | |||
02/17/2023 | Q4 2022 | $7.50 | $15.50 B | |||
11/01/2022 | Q3 2022 | $3.97 | $15.00 B | $14.97 B | ||
08/01/2022 | Q2 2022 | $3.95 | $14.72 B | $14.82 B | ||
05/03/2022 | Q1 2022 | $4.21 | $14.95 B | |||
02/18/2022 | Q4 2021 | $5.94 | $15.06 B | |||
11/01/2021 | Q3 2021 | $7.13 | $14.53 B | $15.28 B | ||
08/02/2021 | Q2 2021 | $4.42 | $13.61 B | $14.44 B | ||
04/30/2021 | Q1 2021 | $4.21 | $13.98 B | |||
02/19/2021 | Q4 2020 | $4.20 | $14.29 B | |||
10/29/2020 | Q3 2020 | $1.97 | $12.85 B | $13.31 B | ||
07/30/2020 | Q2 2020 | $3.19 | $10.09 B | $11.07 B | ||
05/06/2020 | Q1 2020 | $1.72 | $12.86 B | |||
02/20/2020 | Q4 2019 | $3.16 | $13.52 B |
HCA Healthcare, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 28th, 2025 based off last year's report dates.
In the previous quarter, HCA Healthcare, Inc. (:HCA) reported $5.03 earnings per share (EPS) to beat the analysts' consensus estimate of $4.99 by $0.04.
The conference call for HCA Healthcare, Inc.'s latest earnings report can be listened to online.
The conference call transcript for HCA Healthcare, Inc.'s latest earnings report can be read online.
HCA Healthcare, Inc. (:HCA) has a recorded annual revenue of $64.97 B.
HCA Healthcare, Inc. (:HCA) has a recorded net income of $64.97 B. HCA Healthcare, Inc. has generated $19.24 earnings per share over the last four quarters.
HCA Healthcare, Inc. (:HCA) has a price-to-earnings ratio of 13.15 and price/earnings-to-growth ratio is 2.93.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED